Repository logo
 
Publication

Prognostic Factors and Life Expectancy in Canine Leishmaniosis

dc.contributor.authorPereira, Maria Aires
dc.contributor.authorSantos, Rute
dc.contributor.authorOliveira, Ricardo
dc.contributor.authorCosta, Lina
dc.contributor.authorPrata, Ana
dc.contributor.authorGonçalves, Vânia
dc.contributor.authorRoquette, Madalena
dc.contributor.authorVala, Helena
dc.contributor.authorSantos-Gomes, Gabriela
dc.date.accessioned2021-12-17T13:53:40Z
dc.date.available2021-12-17T13:53:40Z
dc.date.issued2020-09-04
dc.date.updated2021-12-12T17:23:13Z
dc.description.abstractCanine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3–4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPereira, M. A., Santos, R., Oliveira, R., Costa, L., Prata, A., Gonçalves, V., Roquette, M., Vala, H., & Santos-Gomes, G. (2020). Prognostic Factors and Life Expectancy in Canine Leishmaniosis. Veterinary Sciences, 7(3), 128. https://doi.org/10.3390/vetsci7030128pt_PT
dc.identifier.doi10.3390/vetsci7030128pt_PT
dc.identifier.issn2306-7381
dc.identifier.slugcv-prod-2591140
dc.identifier.urihttp://hdl.handle.net/10400.19/6936
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.subjectcanine leishmaniosispt_PT
dc.subjectprognostic factorspt_PT
dc.subjectsurvival timept_PT
dc.subjectIRIS stagingpt_PT
dc.subjecttherapy selection and managementpt_PT
dc.titlePrognostic Factors and Life Expectancy in Canine Leishmaniosispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue3pt_PT
oaire.citation.startPage128pt_PT
oaire.citation.titleVeterinary Sciencespt_PT
oaire.citation.volume7pt_PT
person.familyNameVala Correia
person.givenNameHelena Maria
person.identifier.ciencia-id7A1E-E85E-FFA4
person.identifier.orcid0000-0001-6829-4867
rcaap.cv.cienciaid7A1E-E85E-FFA4 | Helena Maria Vala Correia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationcdc3d2e2-df06-40ed-8900-1ecbc8a06c8a
relation.isAuthorOfPublication.latestForDiscoverycdc3d2e2-df06-40ed-8900-1ecbc8a06c8a

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
38_Pereira_et_al_Leish_vetsci-07-00128_20.pdf
Size:
2.23 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description: